Eye (London, England)۲٬۰۲۵مطالعه مشاهده اینمایه شده در PubMed
Ashish Sharma, Luke Nicholson, Clara Vazquez-Alfageme, Vasuki Sivagnanavel, Riccardo Fausto, Maria Cristina Soare, Marta Bautista Salamanca, Lorenzo Fabozzi, Chrysanthi Tsika, Olga Cejudo Corbalan, Alejandro Gomez Verdejo, Taku Wakabayashi, Se Joon Woo, Anton M Kolomeyer, Hana Mansour, Bita Momenaei, Carl D Regillo, International Retina Biosimilar Study Group (Inter BIOS Group)
چکیده
To understand the early experience of ranibizumab biosimilar (FYB 201) that has been approved in the United Kingdom (Ongavia, Teva Pharmaceuticals, Tel Aviv Israel), United States (Cimerli, Sandoz Inc, Princeton, NJ, USA) and Europe (Ranivisio, Bioeq AG, Zug, Switzerland). 1230 patients received…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1038/s41433-025-04030-7